Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making

NCT02158754 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2019-01-31

No results posted yet for this study

Summary

This retrospective study will investigate clinician behavior in diagnosing patients with possible obstructive coronary artery disease who received a Corus CAD (Age/Sex/Gene Expression score - ASGES) result compared to patients who did not have the test performed (matched control patients).

Conditions

Interventions

DIAGNOSTIC_TEST

Corus CAD (ASGES)

Sponsors & Collaborators

  • CardioDx

    lead INDUSTRY

Principal Investigators

  • Mark Monane, MD, FACP · CardioDx

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-05-31
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02158754 on ClinicalTrials.gov